Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 6/2015

01-06-2015 | Autoimmunity (TK Tarrant, Section Editor)

IgG4-Related Ophthalmic Disease: Pooling of Published Cases and Literature Review

Authors: Albert Wu, Nicholas H Andrew, Alan A McNab, Dinesh Selva

Published in: Current Allergy and Asthma Reports | Issue 6/2015

Login to get access

Abstract

In recent years, IgG4-related ophthalmic disease (IgG4-ROD) has emerged as a common cause of orbital inflammation, accounting for a substantial proportion of idiopathic orbital inflammation and lymphoid hyperplasia. The last pooled analysis of published cases was conducted in 2012, but a large number of new cases have been added to the literature since then. In this review, we present the demographic, clinical, histological, and treatment data for 172 published cases of biopsy-confirmed IgG4-ROD. Results are accompanied by a review of the relevant literature.
Literature
1.
Ebbo M, Daniel L, Pavic M, Seve P, Hamidou M, Andres E, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine. 2012;91:49–56.PubMedCrossRef
2.
Carruthers MN, Stone JH, Khosroshahi A. The latest on IgG4-RD: a rapidly emerging disease. Curr Opin Rheumatol. 2012;24:60–9.PubMedCrossRef
3.
4.
Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:57–66.PubMedCrossRef
5.
Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–51.
6.••
Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43:806–17. A series of IgG4-related ophthalmic disease cases, focusing on clinical features, histological features and treatment. Rituximab was used in a large proportion of cases.PubMedCrossRef
7.
Takuma K, Kamisawa T, Anjiki H, Egawa N, Igarashi Y. Metachronous extrapancreatic lesions in autoimmune pancreatitis. Intern Med. 2010;49:529–33.PubMedCrossRef
8.
Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol. 2006;41:1197–205.PubMedCrossRef
9.
Fujinaga Y, Kadoya M, Kawa S, Hamano H, Ueda K, Momose M, et al. Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol. 2010;76:228–38.PubMedCrossRef
10.
Deschamps R, Deschamps L, Depaz R, Coffin-Pichonnet S, Belange G, Jacomet PV, et al. High prevalence of IgG4-related lymphoplasmacytic infiltrative disorder in 25 patients with orbital inflammation: a retrospective case series. Br J Ophthalmol. 2013;97:999–1004.PubMedCrossRef
11.••
Andrew NH, Sladden N, Kearney DJ, Selva D. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD. Br J Ophthalmol. 2014. A histological review of IgG4-related ophthalmic disease cases previously diagnosed as idiopathic orbital inflammation or benign lymphoid hyperplasia, with a focus on histological and clinical features
12.
Takahira M, Ozawa Y, Kawano M, Zen Y, Hamaoka S, Yamada K, et al. Clinical aspects of IgG4-related orbital inflammation in a case series of ocular adnexal lymphoproliferative disorders. Int J Rheumatol. 2012;2012:635473.PubMedCentralPubMed
13.
Sato Y, Ohshima K, Ichimura K, Sato M, Yamadori I, Tanaka T, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int. 2008;58:465–70.PubMedCrossRef
14.•
Japanese study group of IgG4-related ophthalmic disease. A prevalence study of IgG4-related ophthalmic disease in Japan. Jpn J Ophthalmol. 2013;57:573–9. A large study investigating IgG4 staining in cases of orbital lymphoproliferative disorders.
15.
Goto H, Takahira M, Azumi A, Japanese study group for IgG4-Related Ophthalmic Disease. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59:1–7.
16.
Cheuk W, Yuen HK, Chan AC, Shih LY, Kuo TT, Ma MW, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:1159–67.PubMedCrossRef
17.
Go H, Kim JE, Kim YA, Chung HK, Khwarg SI, Kim CW, et al. Ocular adnexal IgG4-related disease: comparative analysis with mucosa-associated lymphoid tissue lymphoma and other chronic inflammatory conditions. Histopathology. 2012;60:296–312.PubMedCrossRef
18.
Wong AJ, Planck SR, Choi D, Harrington CA, Troxell ML, Houghton DC, et al. IgG4 immunostaining and its implications in orbital inflammatory disease. PLoS One. 2014;9:e109847.PubMedCentralPubMedCrossRef
19.
Verdijk RM, Heidari P, Verschooten R, van Daele PL, Simonsz HJ, Paridaens D. Raised numbers of IgG4-positive plasma cells are a common histopathological finding in orbital xanthogranulomatous disease. Orbit. 2014;33:17–22.PubMedCrossRef
20.
Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz’s disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol. 2010;37:1380–5.PubMedCrossRef
21.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol / Jpn Rheum Assoc. 2012;22:21–30.CrossRef
22.
Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol: Off J U S Can Acad Pathol Inc. 2012;25:1181–92.CrossRef
23.
Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol. 2010;17:303–32.PubMedCrossRef
24.
Andrew N, Sladden N, Kearney D, Crompton J, Selva D. Sequential biopsies from immunoglobulin G4-related orbital disease demonstrate progressive fibrosis. Clin Exp Ophthalmol. 2014;42:789–91.CrossRef
25.
Cheuk W, Yuen HK, Chan JK. Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related Sclerosing disease? Am J Surg Pathol. 2007;31:643–5.PubMedCrossRef
26.
McNab AA, McKelvie P. IgG4-Related Ophthalmic Disease. Part I: Background and Pathology. Ophthal Plast Reconstr Surg. 2015.
27.
McNab AA, McKelvie P. IgG4-related ophthalmic disease. Part II: clinical aspects. Ophthal Plast Reconstr Surg. 2015.
28.
Andrew N, Kearney D, Selva D. IgG4-related orbital disease: a meta-analysis and review. Acta Ophthalmol (Copenh). 2013;91:694–700.CrossRef
29.
Pemberton JD, Fay A. Idiopathic sclerosing orbital inflammation: a review of demographics, clinical presentation, imaging, pathology, treatment, and outcome. Ophthal Plast Reconstr Surg. 2012;28:79–83.PubMedCrossRef
30.•
Sogabe Y, Ohshima K, Azumi A, Takahira M, Kase S, Tsuji H, et al. Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefe’s Arch Clin Exp Ophthalmol. 2014;252:531–8. A radiological review of IgG4-related ophthalmic disease which studies frequency of involvement of individual structures.
31.
Heidari P, Verdijk RM, van den Bosch WA, Paridaens D. Biopsy-proven recurrence of unilateral IgG4-related orbital inflammation after 20 years. Orbit. 2014;33:388–91.PubMedCrossRef
32.
Ohno K, Sato Y, Ohshima K, Takata K, Ando M, Abd Al-Kader L, et al. IgG4-related disease involving the sclera. Mod Rheumatol/ Jpn Rheum Assoc. 2014;24:195–8.CrossRef
33.•
Kubota T, Katayama M, Moritani S, Yoshino T. Serologic factors in early relapse of IgG4-related orbital inflammation after steroid treatment. Am J Ophthalmol. 2013;155:373–9 e1. A study which investigates serological changes with treatment of IgG4-related ophthalmic disease.PubMedCrossRef
34.
Koizumi S, Kamisawa T, Kuruma S, Tabata T, Iwasaki S, Chiba K, et al. Clinical features of IgG4-related dacryoadenitis. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2014;252:491–7.CrossRef
35.
Ohshima K, Sogabe Y, Sato Y. The usefulness of infraorbital nerve enlargement on MRI imaging in clinical diagnosis of IgG4-related orbital disease. Jpn J Ophthalmol. 2012;56:380–2.PubMedCrossRef
36.
Ginat DT, Freitag SK, Kieff D, Grove A, Fay A, Cunnane M, et al. Radiographic patterns of orbital involvement in IgG4-related disease. Ophthal Plast Reconstr Surg. 2013;29:261–6.PubMedCrossRef
37.
Origuchi T, Yano H, Nakamura H, Hirano A, Kawakami A. Three cases of IgG4-related orbital inflammation presented as unilateral pseudotumor and review of the literature. Rheumatol Int. 2013;33:2931–6.PubMedCrossRef
38.
Caputo C, Bazargan A, McKelvie PA, Sutherland T, Su CS, Inder WJ. Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: an alternative to corticosteroid therapy. Pituitary. 2014;17:251–6.PubMedCrossRef
39.
Yu WK, Kao SC, Yang CF, Lee FL, Tsai CC. Ocular adnexal IgG4-related disease: clinical features, outcome, and factors associated with response to systemic steroids. Jpn J Ophthalmol. 2014.
40.
Paulus YM, Cockerham KP, Cockerham GC, Gratzinger D. IgG4-positive sclerosing orbital inflammation involving the conjunctiva: a case report. Ocul Immunol Inflamm. 2012;20:375–7.PubMedCrossRef
41.
Kase S, Suzuki Y, Shinohara T, Kase M. IgG4-related lacrimal sac diverticulitis. Orbit. 2014;33:217–9.PubMedCrossRef
42.
Song YS, Choung HK, Park SW, Kim JH, Khwarg SI, Jeon YK. Ocular adnexal IgG4-related disease: CT and MRI findings. Br J Ophthalmol. 2013;97:412–8.PubMedCrossRef
43.
Katsura M, Mori H, Kunimatsu A, Sasaki H, Abe O, Machida T, et al. Radiological features of IgG4-related disease in the head, neck, and brain. Neuroradiology. 2012;54:873–82.
44.
Takano K, Yajima R, Seki N, Abe A, Yamamoto M, Takahashi H, et al. A study of infraorbital nerve swelling associated with immunoglobulin G4 Mikulicz’s disease. Mod Rheumatol/ Jpn Rheum Assoc. 2014;24:798–801.
45.•
Hardy TG, McNab AA, Rose GE. Enlargement of the infraorbital nerve: an important sign associated with orbital reactive lymphoid hyperplasia or immunoglobulin g4-related disease. Ophthalmology. 2014;121:1297–303. A study which investigates whether infraorbital nerve enlargement is suggestive of a diagnosis of IgG4-related ophthalmic disease.PubMedCrossRef
46.
Inoue D, Zen Y, Sato Y, Abo H, Demachi H, Uchiyama A, et al. IgG4-related perineural disease. Int J Rheumatol. 2012;2012:401890.PubMedCentralPubMed
47.•
Hagiya C, Tsuboi H, Yokosawa M, Hagiwara S, Hirota T, Takai C, et al. Clinicopathological features of IgG4-related disease complicated with orbital involvement. Mod Rheumatol/ Jpn Rheum Assoc. 2014;24:471–6. A study of IgG4-related ophthalmic disease with a focus on extra-ophthalmic involvement, histological features and treatment. CrossRef
48.
Ebbo M, Grados A, Guedj E, Gobert D, Colavolpe C, Zaidan M, et al. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res. 2014;66:86–96.CrossRef
49.
Yamamoto M, Yajima H, Takahashi H, Yokoyama Y, Ishigami K, Shimizu Y, et al. Everyday clinical practice in IgG4-related dacryoadenitis and/or sialadenitis: results from the SMART database. Mod Rheumatol/ Jpn Rheum Assoc. 2014;1–6.
50.
Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74:190–5.PubMedCrossRef
51.
Kanari H, Kagami S, Kashiwakuma D, Oya Y, Furuta S, Ikeda K, et al. Role of Th2 cells in IgG4-related lacrimal gland enlargement. Int Arch Allergy Immunol. 2010;152 Suppl 1:47–53.PubMedCrossRef
52.
Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD responder index. Int J Rheumatol. 2012;2012:259408.PubMedCentralPubMed
53.•
Wu A, Andrew NH, Tsirbas A, Tan P, Gajdatsy A, Selva D. Rituximab for the treatment of IgG4-related orbital disease: experience from five cases. Eye. 2015;29:122–8. A case series of biopsy-confirmed steroid-refractory IgG4-related ophthalmic disease treated with rituximab.PubMedCrossRef
54.
Yamamoto M, Nojima M, Takahashi H, Yokoyama Y, Ishigami K, Yajima H, et al. Identification of relapse predictors in IgG4-related disease using multivariate analysis of clinical data at the first visit and initial treatment. Rheumatology. 2015;54:45–9.PubMedCrossRef
55.
Yamamoto M, Takahashi H, Ishigami K, Yajima H, Shimizu Y, Tabeya T, et al. Relapse patterns in IgG4-related disease. Ann Rheum Dis. 2012;71:1755.PubMedCrossRef
56.
Wong PC, Fung AT, Gerrie AS, Moloney G, Maberley D, Rossman D, et al. IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy. Eur J Haematol. 2013;90:250–6.PubMedCrossRef
57.
Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine. 2012;91:57–66.PubMedCrossRef
58.
Yamamoto M, Takahashi H, Tabeya T, Suzuki C, Naishiro Y, Ishigami K, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol/ Jpn Rheum Assoc. 2012;22:414–8.CrossRef
59.
Naresh KN, Barwick T, Karadimitris A. IgG4 positive mucosa associated lymphoid tissue lymphoma of the orbit - lesson of the month. Histopathology. 2014;65:718–21.PubMedCrossRef
60.
Kubota T, Moritani S, Yoshino T, Nagai H, Terasaki H. Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells. J Clin Pathol. 2010;63:1059–65.
61.
Mulay K, Aggarwal E, Jariwala M, Honavar SG. Orbital immunoglobulin-G4-related disease: case series and literature review. Clinical & Experimental Ophthalmology. 2014;42:682–7.
Metadata
Title
IgG4-Related Ophthalmic Disease: Pooling of Published Cases and Literature Review
Authors
Albert Wu
Nicholas H Andrew
Alan A McNab
Dinesh Selva
Publication date
01-06-2015
Publisher
Springer US
Published in
Current Allergy and Asthma Reports / Issue 6/2015
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-015-0530-4

Other articles of this Issue 6/2015

Current Allergy and Asthma Reports 6/2015 Go to the issue

Asthma (WJ Calhoun and S Peters, Section Editors)

Asthma is Different in Women

Food Allergy (T Green, Section Editor)

Review of Environmental Impact on the Epigenetic Regulation of Atopic Diseases

Rhinosinusitis (J Mullol, Section Editor)

Remodeling and Repair in Rhinosinusitis

Allergic Skin Diseases (L Fonacier, Section Editor)

The Other Itch That Rashes: a Clinical and Therapeutic Approach to Pruritus and Skin Picking Disorders

Anaphylaxis and Drug Allergy (DA Khan and M Castells, Section Editors)

Utility of Component-Resolved Diagnostics in Food Allergy

Asthma (WJ Calhoun and S Peters, Section Editors)

The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside